News that matters
Ozempic, Wegovy, and similar drugs may deliver excellent health value, but covering them for millions of eligible patients could overwhelm insurance budgets. Researchers say better long-term support is needed and warn that low-cost compounded versions may carry serious safety risks.
Source: ScienceDaily
A startling new study of a little-known, unpublished short story by Alan Turing challenges our understanding of the man who played a key role in […]
Doctors responding to a major Ebola outbreak in the DRC have been working without protective equipment. Source: Sci Dev Net
Drug development is among the slowest, most failure-prone processes in modern science, with about 90% of drug candidates never reaching the market. Today, artificial intelligence […]